Expanding access to advanced PCR thermocyclers, DNA & RNA purification systems, and hematology analyzers for modern clinical ...

Expanding access to advanced PCR thermocyclers, DNA & RNA purification systems, and hematology analyzers for modern clinical laboratories SINGAPORE, SG / ACCESS Newswire / March 7, 2026 / Dipylon Medi ...

The nucleic acid isolation and purification market is poised for substantial growth driven by the rise in next-gen sequencing ...

This is not incremental progress - it is a step-change that unlocks industrial-scale biology for drug discovery, toxicology, and AI-driven research. Our additional investment reflects our conviction ...

Hepion Pharmaceuticals, Inc. (OTCQB:HEPA), a precision diagnostics company, today announced that it has in-licensed from ...

New workflow validated on Dynamic Devices Lynx® delivers scalable plasmid DNA extraction from Midi to Maxi-prep volumes ...

A team from University of Toronto Engineering is the first to synthesize long noncoding RNA (lncRNA) outside the cell—a new approach to drug discovery that has already yielded some promising ...

When closely related species mate, their offspring sometimes survive but cannot reproduce. This pattern often affects males ...

Next-generation, non-invasive diagnostic platform has potential applications in solid tumor types beyond liver cancer Licensing deal reflects Hepion's strategic shift to advancing clinically proven li ...

Explore the breakthrough of lab-made lncRNA by University of Toronto Engineering for new drug discovery potential.

The EXPANDIA project demonstrates how cross-sector partnerships and RT-LAMP diagnostics can expand testing capacity in low-resource regions. The collaboration enabled cost-effective, saliva-based ...